Mar 15, 2023 / 02:15PM GMT
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
Good morning, and welcome to Day 2 of the Barclays Global Health Conference. My name is Carter Gould, Senior Biopharma Analyst. Please welcome Gilead to the major screen here, Merdad, if you probably can't see it or maybe you can, you're about 20 feet tall here, behind us.
Merdad V. Parsey - Gilead Sciences, Inc. - Chief Medical Officer
(inaudible) at all.
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
Thank you for still agreeing to do the chat, even though you couldn't be here in person. Merdad Parsey, CMO of the Gilead and excited to do a Q&A. But Merdad, want to give you the opportunity if you wanted to make any opening comments first.
Merdad V. Parsey - Gilead Sciences, Inc. - Chief Medical Officer
Well, first, Carter. I really apologize. I was looking forward to joining you all and I threw out my back and have been essentially unable to walk for the past couple of
Gilead Sciences Inc at Barclays Global Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers